Quarter Period Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7351594

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Quarter period statement of income
Statement of income
Net sales
87,267,000,000 JPY
80,707,000,000 JPY
Cost of sales
48,953,000,000 JPY
43,652,000,000 JPY
Gross profit (loss)
38,314,000,000 JPY
37,055,000,000 JPY
Selling, general and administrative expenses
33,848,000,000 JPY
32,352,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
4,465,000,000 JPY
4,702,000,000 JPY
Non-operating income
Interest income
34,000,000 JPY
6,000,000 JPY
Dividend income
459,000,000 JPY
449,000,000 JPY
Non-operating income
661,000,000 JPY
712,000,000 JPY
Non-operating expenses
Interest expenses
49,000,000 JPY
50,000,000 JPY
Non-operating expenses
73,000,000 JPY
78,000,000 JPY
Ordinary profit (loss)
5,053,000,000 JPY
5,336,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
4,000,000 JPY
Extraordinary income
991,000,000 JPY
1,332,000,000 JPY
Extraordinary losses
Impairment losses
JPY
105,000,000 JPY
Extraordinary losses
895,000,000 JPY
707,000,000 JPY
Profit (loss) before income taxes
5,150,000,000 JPY
5,961,000,000 JPY
Income taxes
1,235,000,000 JPY
1,583,000,000 JPY
Profit (loss)
3,914,000,000 JPY
4,377,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.